Colorectal Cancer Biology, Diagnosis, and Therapeutic Approaches.
Dariya B, Aliya S, Merchant N, Alam A, Nagaraju GP.
Crit Rev Oncog. 2020;25(2):71-94. doi: 10.1615/CritRevOncog.2020035067.
Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy.
Bai Z, Zhou Y, Ye Z, Xiong J, Lan H, Wang F.
Front Immunol. 2022 Jan 14;12:808964. doi: 10.3389/fimmu.2021.808964. eCollection 2021.
Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling.
Agorku DJ, Bosio A, Alves F, Ströbel P, Hardt O.
Cancer Lett. 2024 Jul 28;595:216985. doi: 10.1016/j.canlet.2024.216985. Epub 2024 May 29.
Increased risk of hemorrhage in metastatic colorectal cancer patients treated with bevacizumab: An updated meta-analysis of 12 randomized controlled trials.
Zhu X, Tian X, Yu C, Hong J, Fang J, Chen H.
Medicine (Baltimore). 2016 Aug;95(34):e4232. doi: 10.1097/MD.0000000000004232.
Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer.
Becattini C, Pace U, Pirozzi F, Donini A, Avruscio G, Rondelli F, Boncompagni M, Chiari D, De Prizio M, Visonà A, De Luca R, Guerra F, Muratore A, Portale G, Milone M, Castagnoli G, Righini M, Martellucci J, Persiani R, Frasson S, Dentali F, Delrio P, Campanini M, Gussoni G, Vedovati MC, Agnelli G.
Blood. 2022 Aug 25;140(8):900-908. doi: 10.1182/blood.2022015796.
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial.
Lou E, Choudhry MS, Starr TK, Folsom TD, Bell J, Rathmann B, DeFeo AP, Kim J, Slipek N, Jin Z, Sumstad D, Klebanoff CA, Ladner K, Sarkari A, McIvor RS, Murray TA, Miller JS, Rao M, Jensen E, Ankeny J, Khalifa MA, Chauhan A, Spilseth B, Dixit A, Provenzano PP, Pan W, Weber D, Byrne-Steele M, Henley T, McKenna DH, Johnson MJ, Webber BR, Moriarity BS.
Lancet Oncol. 2025 May;26(5):559-570. doi: 10.1016/S1470-2045(25)00083-X. Epub 2025 Apr 29.
Neutrophil and Colorectal Cancer.
Masui H, Kawada K, Obama K.
Int J Mol Sci. 2024 Dec 24;26(1):6. doi: 10.3390/ijms26010006.
Emergency Presentations of Colorectal Cancer.
Baer C, Menon R, Bastawrous S, Bastawrous A.
Surg Clin North Am. 2017 Jun;97(3):529-545. doi: 10.1016/j.suc.2017.01.004.
Immunotherapy for colorectal cancer.
Koido S, Ohkusa T, Homma S, Namiki Y, Takakura K, Saito K, Ito Z, Kobayashi H, Kajihara M, Uchiyama K, Arihiro S, Arakawa H, Okamoto M, Gong J, Tajiri H.
World J Gastroenterol. 2013 Dec 14;19(46):8531-42. doi: 10.3748/wjg.v19.i46.8531.
Where Do We Stand With Aspirin for the Prevention of Colorectal Cancer? The USPSTF Recommendations.
Chan AT, Ladabaum U.
Gastroenterology. 2016 Jan;150(1):14-8. doi: 10.1053/j.gastro.2015.11.018. Epub 2015 Nov 18.
